EZZ Life Science Holdings Limited (ASX:EZZ) Insider Mark (Qizhou) Qin Acquires 90,830 Shares of Stock

EZZ Life Science Holdings Limited (ASX:EZZ) insider Mark (Qizhou) Qin bought 90,830 shares of the company’s stock in a transaction on Wednesday, December 11th. The stock was purchased at an average cost of A$2.71 ($1.73) per share, for a total transaction of A$246,149.30 ($156,782.99).

EZZ Life Science Price Performance

The company has a debt-to-equity ratio of 0.58, a quick ratio of 4.53 and a current ratio of 5.96.

EZZ Life Science Increases Dividend

The business also recently declared a Final dividend, which was paid on Sunday, December 8th. Shareholders of record on Sunday, December 8th were given a $0.02 dividend. The ex-dividend date was Monday, November 4th. This represents a dividend yield of 0.57%. This is a boost from EZZ Life Science’s previous Final dividend of $0.01. EZZ Life Science’s payout ratio is currently 37.50%.

About EZZ Life Science

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand.